T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fortinet
FTNT
|
+$2.09B |
| 2 |
Rockwell Automation
ROK
|
+$1.46B |
| 3 |
Autodesk
ADSK
|
+$1.19B |
| 4 |
Citigroup
C
|
+$1.11B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.23B |
| 2 |
GE Aerospace
GE
|
+$2.12B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.46B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.17B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Curtiss-Wright
CW
$18.7B
| $112M | 0.01% |
439,500
-738
| -0.2% | -$189K |
|
527
OR Royalties Inc.
OR
$6.69B
| $110M | 0.01% |
+6,688,471
| New | +$110M |
|
528
Parker-Hannifin
PH
$96.9B
| $109M | 0.01% |
196,960
+15,079
| +8% | +$8.38M |
|
529
Arthur J. Gallagher & Co
AJG
$75.2B
| $109M | 0.01% |
435,575
-111,064
| -20% | -$27.8M |
|
530
Moderna
MRNA
$9.46B
| $109M | 0.01% |
1,019,197
-88,298
| -8% | -$9.41M |
|
531
ZTO Express
ZTO
$15.4B
| $108M | 0.01% |
5,180,444
+1,968,971
| +61% | +$41.2M |
|
532
The Ensign Group
ENSG
$9.59B
| $108M | 0.01% |
870,018
-1,428
| -0.2% | -$178K |
|
533
Verisk Analytics
VRSK
$36.7B
| $108M | 0.01% |
456,674
-10,955
| -2% | -$2.58M |
|
534
MoonLake Immunotherapeutics
MLTX
$3.44B
| $107M | 0.01% |
2,135,883
-178,129
| -8% | -$8.95M |
|
535
Baidu
BIDU
$37B
| $107M | 0.01% |
1,017,341
+84,776
| +9% | +$8.93M |
|
536
Permian Resources
PR
$9.99B
| $107M | 0.01% |
6,054,560
+5,012,287
| +481% | +$88.5M |
|
537
Kraft Heinz
KHC
$31.5B
| $107M | 0.01% |
2,896,155
-12,570,383
| -81% | -$464M |
|
538
Manhattan Associates
MANH
$12.8B
| $107M | 0.01% |
426,729
+29,063
| +7% | +$7.27M |
|
539
Prothena Corp
PRTA
$447M
| $104M | 0.01% |
4,201,771
-35,580
| -0.8% | -$881K |
|
540
NiSource
NI
$19.2B
| $104M | 0.01% |
3,754,122
-218,619
| -6% | -$6.05M |
|
541
NetEase
NTES
$92.3B
| $104M | 0.01% |
+1,001,816
| New | +$104M |
|
542
Medpace
MEDP
$13.4B
| $104M | 0.01% |
256,100
+3,222
| +1% | +$1.3M |
|
543
New Oriental
EDU
$9.04B
| $103M | 0.01% |
+1,190,859
| New | +$103M |
|
544
Vera Therapeutics
VERA
$1.55B
| $103M | 0.01% |
+2,393,029
| New | +$103M |
|
545
Murphy USA
MUSA
$7.26B
| $103M | 0.01% |
245,220
+1,519
| +0.6% | +$637K |
|
546
Akero Therapeutics
AKRO
$3.46B
| $103M | 0.01% |
4,060,479
+384,555
| +10% | +$9.71M |
|
547
Ciena
CIEN
$18.4B
| $102M | 0.01% |
2,062,394
+1,961,513
| +1,944% | +$97M |
|
548
Builders FirstSource
BLDR
$15.5B
| $101M | 0.01% |
484,907
-27,959
| -5% | -$5.83M |
|
549
Bruker
BRKR
$4.63B
| $99.7M | 0.01% |
1,061,624
-311,924
| -23% | -$29.3M |
|
550
Wynn Resorts
WYNN
$12.8B
| $99.4M | 0.01% |
972,291
-20,883
| -2% | -$2.13M |
|